Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles

Author： Mirochnik Yelena   Rubenstein Marvin   Guinan Patrick  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.15, Iss.5, 2007-06, pp. : 342-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two Constructed Antibody-Derived Delivery Vehicles for Targeting Oligodeoxynucleotides to Prostate Tumors Expressing Prostate Specific Antigen

By Mirochnik Yelena   Rubenstein Marvin   Guinan Patrick  

Drug Delivery, Vol. 11, Iss. 3, 2004-05 ,pp. : 161-167

Informa Healthcare

Access to resources Recommend Favorite

Antibody-based cancer therapy

By Baxevanis Constantin N  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-based antiangiogenic cancer therapy

By Sanz Laura   Álvarez-Vallina Luis  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1235-1245

Informa Healthcare

Access to resources Recommend Favorite